Omicron Surge Forces South Korea to End GPS Monitoring, Some Checkups

South Korea had been seen as a success story during the earlier part of the pandemic after it contained infections effectively.

Advertisement
By Associated Press | Updated: 7 February 2022 14:45 IST
Highlights
  • Officials had already been forced to expand at-home treatments
  • Omicron is spreading much faster than previous versions of the virus
  • 270 patients were in serious or critical conditions as of Monday

Officials had already been forced to reshape testing policy around rapid antigen test kits

Photo Credit: Unsplash/ Prasesh Shiwakoti

South Korea will no longer use GPS monitoring to enforce quarantines and will also end daily checkup calls to low-risk coronavirus patients as a fast-developing Omicron surge overwhelms health and government workers.

The speed of transmissions has made it impossible to maintain a tight and proactive medical response, Jeong Eun-kyeong, the country's top infectious disease expert, said Monday.

The Korea Disease Control and Prevention Agency reported 38,691 new cases of the virus, a nine-fold increase from the levels seen in mid-January, when Omicron became the country's dominant strain. Jeong said the country may see daily jumps of 130,000 or 170,000 by late February.

Advertisement

South Korea had been seen as a success story during the earlier part of the pandemic after it contained infections and hospitalisations more effectively than most countries in the West. Health authorities worked closely with biotech companies to ramp up laboratory tests and aggressively mobilised technological tools and public workers to trace contacts and enforce quarantines.

But the country's strengths have been rendered irrelevant by the unprecedented spike in infections fueled by the Omicron variant, which has stretched health and administrative resources.

Officials had already been forced to expand at-home treatments, reduce quarantine periods, and reshape testing policy around rapid antigen test kits, despite concerns over their reliability, to save laboratory tests for people in their 60s or older and those with existing medical conditions who are at higher risk for serious illness.

Advertisement

The plans to further ease the monitoring and quarantines came as health and public workers struggle to keep up with the near 150,000 people being treated at home for mild or moderate symptoms, which have led to delays in drug prescriptions and has paralysed contact tracing.

Officials say public workers who had been monitoring virus carriers through GPS-enabled smartphone apps will now be assigned to help with at-home treatments. Virus carriers will no longer be required to report to local health offices when they leave home to visit doctors, while their cohabiting family members can now freely go out to buy food, medicine and other essentials.

Advertisement

Low-risk virus carriers, who are in their 50s or younger and have no pre-existing medical conditions, will now be left to monitor their conditions on their own and contact local hospitals if their symptoms worsen. Health workers will still make daily checkup calls to people in their 60s and older or those with pre-existing medical conditions.

“We are planning to transition toward an anti-virus strategy that's concentrated on maintaining essential social functions while dealing with huge numbers of infections and people placed under quarantine,” Jeong, the KDCA's commissioner, said during a government briefing.

Advertisement

While Omicron is spreading much faster than previous versions of the virus, the rates of hospitalisation and death have so far been lower than cases linked to delta, which drove a devastating surge in December and early January.

The KDCA said 270 patients were in serious or critical conditions as of Monday, while less than 46 percent of the country's intensive care units designated for COVID-19 treatment were occupied. Still, experts say the country's rapidly growing caseload is likely to drive up hospitalisations in coming weeks.

As of Monday, 86 percent of a population of more than 51 million people have been fully vaccinated and nearly 55 percent have received booster shots.


Are Oppo's new flagship phones any good? We discuss this on Orbital, the Gadgets 360 podcast. Orbital is available on Spotify, Gaana, JioSaavn, Google Podcasts, Apple Podcasts, Amazon Music and wherever you get your podcasts.
Affiliate links may be automatically generated - see our ethics statement for details.
 

Catch the latest from the Consumer Electronics Show on Gadgets 360, at our CES 2026 hub.

Further reading: South Korea, GPS, Coronavirus, COVID 19
Advertisement

Related Stories

Popular Mobile Brands
  1. Top Deals on Phones Under Rs. 50,000 During Amazon's Republic Day Sale
  2. OpenAI Has Officially Confirmed Ads Are Coming to ChatGPT
  3. Amazon Great Republic Day Sale: Top Laptop Deals Under Rs. 40,000
  4. Redmi Note 15 Pro, Note 15 Pro+ 5G Could Launch in India on This Date
  5. Amazon Great Republic Day Sale: Top Deals on Smartwatches Under Rs. 10,000
  1. OpenAI to Begin Testing Ads in ChatGPT, Says Responses Will Not Be Influenced
  2. Gurram Paapi Reddy OTT Release: When, Where to Watch This Telugu Crime Comedy Thriller
  3. Hypothetical ‘Dark Stars’ Could Rewrite Early Cosmic History, Research Suggests
  4. Honor Magic 8 Pro Air Key Features Confirmed; Company Teases External Lens for Honor Magic 8 RSR Porsche Design
  5. Lava Blaze Duo 3 India Launch Date Announced; Colour Options Teased Ahead of Debut
  6. Resident Evil Requiem Gets New Leon Gameplay at Resident Evil Showcase
  7. After ChatGPT Translate, Google Releases Multiple Open-Source Translation Models
  8. Realme Buds Clip India Launch Timeline Confirmed: Expected Specifications, Features
  9. NASA's James Webb Space Telescope Might Have Spotted Hidden Supermassive Black Holes
  10. Tere Ishk Mein Reportedly Streams on OTT Soon: All You Need to Know About Dhanush and Kriti Sanon-Starrer
Gadgets 360 is available in
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.